Two xenograft models in which patient-derived AML cells were transplanted to cynomolgus monkeys and mice, respectively, showed that CLL-1-targeted ADCs exhibited almost complete depletion of leukemic cells and tumor growth inhibition, respectively [93,94]. Here, CLEC12A is linked to acute myeloid leukemia.